Genomic Health Inc (GHDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,877 | -883 | 8,249 | 6,290 | 2,577 |
| Depreciation Amortization | 3,148 | 1,545 | 5,471 | 3,974 | 2,765 |
| Accounts receivable | -4,437 | -4,792 | -1,176 | 1,151 | -622 |
| Accounts payable and accrued liabilities | -1,188 | -898 | -2,144 | -3,633 | -3,536 |
| Other Working Capital | -3,201 | -6,565 | -3,046 | -1,461 | -4,464 |
| Other Operating Activity | 14,222 | 10,095 | 18,608 | 13,504 | 11,741 |
| Operating Cash Flow | $4,667 | $-1,498 | $25,962 | $19,825 | $8,461 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,638 | 2,098 | -13,410 | -1,371 | 10,772 |
| PPE Investments | -4,411 | -2,217 | -9,850 | -6,170 | -3,493 |
| Purchase Of Investment | N/A | N/A | -4,963 | -1,409 | -400 |
| Investing Cash Flow | $2,227 | $-119 | $-28,223 | $-8,950 | $6,879 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,509 | 3,158 | 18,764 | 14,215 | 8,805 |
| Common Stock Repurchased | -15 | -15 | -30,095 | 0 | 0 |
| Other Financing Activity | -2,571 | -2,434 | -1,272 | 0 | 0 |
| Financing Cash Flow | $7,923 | $709 | $-12,603 | $14,215 | $8,805 |
| Beginning Cash Position | 18,005 | 18,005 | 32,869 | 32,869 | 32,869 |
| End Cash Position | 32,822 | 17,097 | 18,005 | 57,959 | 57,014 |
| Net Cash Flow | $14,817 | $-908 | $-14,864 | $25,090 | $24,145 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,667 | -1,498 | 25,962 | 19,825 | 8,461 |
| Capital Expenditure | -4,415 | -2,217 | -10,056 | -6,170 | -3,493 |
| Free Cash Flow | 252 | -3,715 | 15,906 | 13,655 | 4,968 |